Ethanol: Clinical Trials

5 trials of Ethanol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Unknown 5
Phase 21Unknown 1

Follow Ethanol: new trials by email Literature Review of Ethanol trials Research Report on Ethanol

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
New Treatment for COVID-19 Using Ethanol Vapor Inhalation .
Ethanol with Asprin - Covid-19, Drug Effect
Phase 3UnknownMansoura University802020-12-012020-10-28
Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination
Alcohol, No alcohol - Skin Infection
Phase 3UnknownUniversity of Toronto1702017-05-012017-05-02
Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
Nicotine replacement therapy - Transdermal nicotine patch, Nicotine replacement therapy - Nicotine gum, Nicotine replacement therapy - Nicotine lozenge - Nicotine Dependence, Tobacco Use
Phase 3UnknownMark Vander Weg4112013-07-012017-07-11
Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord
Hygiene, Usual alcohol care - Infection, Skin Diseases, Bacterial
Phase 3UnknownASST Fatebenefratelli Sacco4002011-05-012011-06-08
¹³C-Methacetin Breath Test (MBT) Methodology Study
13C Methacetin Breath Test, Grape fruit juice, Non selective beta blocker - Propranolol - Healthy Subjects, Chronic Liver Disease
Phase 2 / Phase 3UnknownHadassah Medical Organization2010-09-012012-08-28

Conditions studied

Alcohol Drinking (1)  ·  Body Weight (1)  ·  COVID-19 (1)  ·  Cellulitis (1)  ·  Depression (1)  ·  Fibrosis (1)  ·  Granuloma (1)  ·  Infections (1)  ·  Skin Diseases, Bacterial (1)  ·  Smoking Cessation (1)  ·  Tobacco Use (1)  ·  Tobacco Use Disorder (1)

Sponsors

ASST Fatebenefratelli Sacco (1)  ·  Hadassah Medical Organization (1)  ·  Mansoura University (1)  ·  Mark Vander Weg (1)  ·  University of Toronto (1)

Countries

Canada (1)  ·  Israel (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Anna Taddio, PhD (1)  ·  Cristina Meroni (1)  ·  Ludovica Tagliabue, MD (1)  ·  Maria Teresa Garavaglia (1)  ·  Mark W. Vander Weg, Ph.D. (1)

Results publications

PMID 37142273